Dr. Vinay Prasad's Views on Key ASCO Breast Cancer Trials
Dr. Vinay Prasad is now Director of FDA's CBER Division, Review his thoughts on NATALEE, DESTINY-Breast04, and postMONARCH breast cancer clinical trials
ASCO23 Flashback: Dr. Prasad's Video Criticisms of ADAURA
Amid the hype of the plenary session at ASCO23, Dr. Vinay Prasad criticized the study design and ethical implementation of AstraZeneca's ADAURA trial.
AI Generated KOL Network Mapping - ivonescimab discussion
Key Opinion Leader Network Mapping through KOL Pulse AI generated social network visualization of KOL discussions of HARMONi-A from #ASCO24
Using AI to Understand ivonescimab - KOL Pulse AI Demo
Akeso biopharma published a preprint of the mechanism of action of ivonescimab. Can the KOL Pulse AI provide context to KOL questions about HARMONi-A?
Top Lung Cancer Digital Opinion Leaders of #ASCO24
Top 10 Digital Opinion Leaders in Lung Cancer in the US including Dr. Stephen Liu, Dr. Nathan Pennell, Dr. Patrick Forde, Dr. Jack West, Dr. Brendon Stiles
Prepare for Social Discussion of #ASCO24
KOL Pulse AI is a social listening tool for ASCO24. It provides Digital opinion leader and key opinion leader profiles and provides their social sentiment analy…